Literature DB >> 19127942

The European paediatric initiative: 1 year of experience.

Agnès Saint-Raymond1, Nathalie Seigneuret.   

Abstract

The European Regulation on medicines for pediatric use entered into force on 26 January 2007. It changes dramatically the way medicines are developed for children. This regulation will increase availability of and information on pediatric medicines through high quality, ethical research.

Entities:  

Mesh：

Year:  2009        PMID： 19127942     DOI： 10.2165/0148581-200911010-00004

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


  5 in total

1.  Straight talk with ... Agnès Saint Raymond. Interview by Genevive Bjorn.

Authors:  Agnès Saint Raymond
Journal:  Nat Med       Date:  2009-04       Impact factor: 53.440

Review 2.  Disease registries and outcomes research in children: focus on lysosomal storage disorders.

Authors:  Simon Jones; Emma James; Suyash Prasad
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

3.  Challenges in conducting clinical trials in children: approaches for improving performance.

Authors:  Steven E Kern
Journal:  Expert Rev Clin Pharmacol       Date:  2009-11-01       Impact factor: 5.045

Review 4.  Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency.

Authors:  Klaus Rose; Michael G Spigarelli
Journal:  Children (Basel)       Date:  2015-03-23

Review 5.  Historical ethnobotanical review of medicinal plants used to treat children diseases in Romania (1860s-1970s).

Authors:  Madalina Petran; Dorin Dragos; Marilena Gilca
Journal:  J Ethnobiol Ethnomed       Date:  2020-03-24       Impact factor: 2.733
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.